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ABSTRACT
Cryptococcosis is an opportunistic fungal infection causes significant disease 
predominantly in immunocompromised patients. Here we present an excepcional 
case of disseminated cryptococcosis with pulmonary and cerebral involvement in an 
immunocompetent patient with no apparent predisposing factors at the time of hospital 
admission. We described a case of an apparently immunocompetent 66-years old man admitted 
to hospital with a one-month history of cough, fever and vertigo. During hospitalization, thorax 
imaging was suggestive of lung metastasis, therefore, he went through several investigations. 
During hospitalization, he developed neurological symptoms and subsequently underwent 
a lumbar puncture. Cerebrospinal fluid (CSF) culture was positive for Cryptococcus spp. 
isolated on Sabouraud’s dextrose agar and bird seed agar. In addition, the direct microscopy 
examination was positive for the India ink test, as well as with the latex agglutination test for 
cryptococcal polysaccharide antigen (CrAg) in CSF, while serum CrAg was negative. Despite 
the absence of classic immunocompromising features, he was treated with amphotericin B and 
fluconazole due to suspected disseminated cryptococcal infection. Later, he was diagnosed 
with prostatic adenocarcinoma. Upon successful completion of treatment for disseminated 
cryptococcosis, the patient underwent radical prostate ablation surgery as a treatment 
forprostatic adenocarcinoma. This exceptional case emphasizes the high degree of suspicion of 
atypical infections, and in these cases, it is particularly important to consider fungal infections 
in hitherto healthy patients with no apparent predisposing factors. Although Cryptococcus 
spp. is predominantly reported in patients with hematological malignancies, cryptococcosis 
investigation should also be considered as part of the initial workup of patients with a new 
diagnosis of a solid tumour prior to chemotherapy or radiotherapy.
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INTRODUCTION
Cryptococcosis is an opportunistic fungal infection that has been historically 
regarded as a disease of immunocompromised patients. Cryptococcus is an 
ubiquitous yeast, and the most common species causing disease are Cryptococcus 
neoformans and C. gatii1. Cryptococcus neoformans is the predominant cause of 
cryptococcosis among people living with the human immunodeficiency virus (HIV), 
but it can also be found in other immunocompromised hosts such as solid organ 
transplant recipients, patients on prolonged glucocorticoid therapy, hematologic 
malignancies and in those with impaired cell-mediated immunity2,3. 
Although disseminated cryptococcosis is a rare condition that almost always 
occurs in immunocompromised hosts especially in persons living with HIV4, there 
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is growing evidence suggesting that disseminated disease 
may also occur in otherwise healthy, HIV-uninfected, non-
transplant patients in whom an underlying predisposing 
factor may not be apparent5,6. Here we present an 
exceptional case report of disseminated cryptococcosis 
with pulmonary and cerebral involvement in an apparently 
immunocompetent patient with no apparent predisposing 
factors at the time of hospital admission. 
CASE REPORT
A previously healthy 66-years old man was admitted 
to hospital with a one-month history of cough, fever 
and vertigo, being initially treated with macrolides and 
cephalosporins for 3 weeks in the community with an 
unsuccessful outcome. He had a past medical history of 
myocardial infarction and revascularization through stent 
insertion one year prior to hospital admission. He worked 
as an engineer in South-West Africa for 6 years, without 
previous exposure to pigeons. At the time of admission, 
he was hemodynamically stable with a blood pressure of 
130/70 mm/Hg, heart rate of 90 bpm, oxygen saturation of 
96% in room air, although he was tachypneic (respiratory 
rate of 25 bpm) and had temperature of 37.8 ºC. Chest 
examination revelated generalized crepitations in both 
lungs, cardiac auscultation was normal, abdomen was soft 
and non-tender with no organ enlargement and neurological 
examination was unremarkable. Laboratory findings 
showed high erythrocyte sedimentation rate of 88.0 mm/h 
(normal range 0-20 mm/h), C-reactive protein (CRP) 
85.2 mg/L (normal range 0-5 mg/L) and white blood count 
19,500/µL (4,000-10,000/µL) with neutrophilia of 
83.3%. Other biochemistry and hematology results were 
unremarkable. Electrocardiogram showed left bundle 
branch block with occasional ventricular arrhythmias. 
The chest X-ray showed bilateral pulmonary opacities 
(Figure 1A). Subsequently, the patient underwent thorax 
computed tomography (CT) scan that revealed multiple 
bilateral patchy opacities with particular nodular excavations 
with no evidence of mediastinal lymph node enlargement 
(Figure 1B). Due to the pathological images seen in the 
lungs, the patient received azithromycin 1 x 500 mg BD 
i.v. and ceftriaxone 2 x 1g OD i.v. Despite the antibiotic 
treatment, the follow-up chest X-ray showed persistence of 
abnormal images, raising the suspicion of lung metastases. 
He then underwent multiple microbiological 
investigations including sputum smear, sputum culture, 
blood cultures, blood borne viruses screening (hepatitis B, 
hepatitis C and HIV) and serology for Legionella sp., 
Mycoplasma sp., Histoplasma capsulatum, Coccidioides sp., 
Candida sp. and Aspergillus sp., that were all negative. 
Subsequently, fiberoptic bronchoscopy was performed with 
transbronchial biopsy. Histopathological findings of the lung 
tissue were suggestive of non-specific chronic bronchitis or 
peribronchitis. The bronchoalveolar lavage (BAL) culture 
was negative for bacterial and fungal pathogens as well as 
Mycobacterium sp. Arterial blood gas analysis was normal 
and lung function testing were within normal range with 
FVC of 102% and FEV1 of 99%. QuantiFERON-TB gold 
test was also negative. 
Later during hospitalization, the patient developed 
headache with worsening of vertigo and fever. Therefore, 
endocranial contrasted CT scan was performed and did 
not reveal any metastasis or acute brain hemorrhage. 
Subsequently, lumbar puncture was performed to 
rule out an infectious or malignant cause of central 
nervous system involvement. The cerebrospinal fluid 
(CSF) results revealed an increased opening pressure 
(150 cm/H2O) (normal range 10-20 cm/H2O), pleocytosis 
with predominance of neutrophils (122/mm3; 90% neutrophils 
and 10% lymphocytes), hyperproteinorrachia (121 mg/dL) 
and hypoglycorrhachia (CSF glycorrhachia/plasmaglucose: 
1.7/4.2 mmol/L). The cerebrospinal fluid (CSF) culture 
was positive for Cryptococcus spp. in Sabouraud’s dextrose 
Figure 1 - A) Chest X-ray showing bilateral pulmonary opacities; B) Initial thoracic CT scan showing multiple bilateral patchy 
opacities with nodular excavations; C) Follow-up thoracic CT scan performed 2-months after the antifungal treatment showing a 
significant improvement with remaining fibrotic changes. 
Rev Inst Med Trop São Paulo. 2020;62:e3
An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient
Page 3 of 4
agar; in addition to direct microscopy examination that was 
positive for India ink test as well as latex agglutination test 
for cryptococcal polysaccharide antigen (CrAg) in CSF 
(titer 1:32), while serum CrAg was negative. The isolate 
was identified as Cryptococcus spp. using bird seed agar, a 
selective medium for Cryptococcus spp. differential isolation 
(Staib’s medium, HiMedia, India). The brown pigmented 
colonies of Cryptococcus spp. grew after 2 days at 37 °C. 
Despite the absence of classic immunocompromising 
features, i.v. amphotericin B (AmB) deoxycholate formulation 
(1 mg/kg/day) in combination with oral fluconazole 
(800 mg/day) was initiated for suspected disseminated 
cryptococcosis. 
Although he had no red flag symptoms indicative of 
malignancy, he had a complete panel of tests including 
tumor markers which were all within normal ranges 
except for the prostatic specific antigen (PSA) which was 
26 ng/mL (normal range 0-4.5 ng/mL). Given the increased 
PSA levels, a trans-urethral prostatic biopsy was performed, 
and the diagnosis of prostatic adenocarcinoma was confirmed. 
After 7 days of treatment, the patient developed acute 
renal injury; therefore, i.v. AmB was interrupted and oral 
fluconazole (800 mg/day) was continued. The follow-up 
CSF after 4 weeks of high dose oral fluconazole treatment 
revealed significant improvement (2 lymphocytes, 
glycorrhachia 3.0 mmol/L, proteinorrhachia 35 mg/dL), 
while the CrAg titer in CSF was 1:8. He then continued 
on 400 mg/day oral fluconazole to complete 6 months 
therapy in total. Diagnostic follow-up after 3 months therapy 
showed negative CrAg in CSF. The follow-up thoracic 
CT scan 2 months after treatment showed significant 
improvement with remaining fibrotic changes (Figure 1C). 
Upon successful completion of treatment for 
disseminated cryptococcosis, the patient went a radical 
ablation surgery for prostatic adenocarcinoma with no 
requirement for additional cancer treatment. According to 
the follow-up visit 1 year after surgery and 1.5 years after 
fluconazole treatment, the patient recovered well, with no 
sequelae remaining. 
DISCUSSION
This exceptional case report emphasises the challenges 
of recognising opportunistic infections in hitherto healthy, 
HIV-negative, non-transplanted patients with no apparent 
predisposing factors. Although Cryptococcus spp. is 
predominantly reported in patients with haematological 
malignancies3, this case indicates that cryptococcosis 
should also be considered as part of the differential 
diagnosis of patients with solid tumours, especially prior 
to chemotherapy or radiotherapy. 
The respiratory tract acts as the primary portal of entry 
for Cryptococcus spp.1. As observed in this case, yeasts 
may remain dormant in subpleural spaces for years after 
inhalation, and fungal reactivation will occur when local 
immunity is suppressed1. Pulmonary cryptococcosis is 
usually asymptomatic or mildly symptomatic and tends to 
resolve spontaneously. However, in the immunocompromised 
host, pulmonary disease is usually symptomatic and can 
rapidly progress to acute respiratory distress syndrome5. 
After pulmonary cryptococcosis is established, the infection 
can spread to the central nervous system (CNS) resulting in 
meningitis, meningoencephalitis and disseminated infection4. 
Disseminated cryptococcosis in immunocompetent patients is 
uncommon, usually atypical and often late diagnosed5,6. CNS 
involvement in immunocompetent patients is particularly 
rare2,5 so that lumbar puncture is not always warranted. 
However, if an apparently immunocompetent patient has 
CNS symptoms, or a high CrAg titer (>1:8) regardless of 
any CNS symptoms, a lumbar puncture is recommended to 
evaluate the CNS involvement7.
Disseminated cryptococcosis is diagnosed by positive 
culture obtained from at least two distinct sites, or 
by positive blood culture4. Diagnosis of pulmonary 
cryptococcosis involves a combination of chest imaging, 
sputum or BAL fungal cultures, serum CrAg and tissue 
histology. In this case, the patient had nodular chest X-ray 
and CT changes, but BAL, sputum cultures and serum CrAg 
were negative. Although CrAg is a rather sensitive method 
(up to 100%) in people living with HIV, it is less reliable in 
immunocompetent patients5. According to previous studies, 
in immunocompetent populations, CrAg has a sensitivity 
of 56% in pulmonary disease and 86% in CNS disease5. In 
the present case, Cryptococcus spp. was only observed in 
CSF, and although the pulmonary cryptococcosis was not 
microbiologically confirmed, resolution of CT changes after 
treatment supports the pulmonary involvement. We can 
conclude that diagnosis could be made by positive blood or 
CSF culture or positive culture of other sites, according to 
the clinical manifestation, not requiring a positive culture 
in at least two sites, as one deep site is enough to confirm 
the diagnosis. Although the prostate gland is not an unusual 
site of cryptococcal infection and has been recognized as 
a reservoir of disseminated disease, we were not able to 
confirm the involvement of the prostate in this case. 
The radiological manifestations of cryptococcosis can 
be atypical among immunocompetent patients, sometimes 
mimicking lung cancer or lung metastasis8,9. In a study by 
Song et al. among 23 HIV-negative patients with pulmonary 
cryptococcosis, nine were diagnosed with tuberculosis 
and six with metastatic lung cancer10. The most common 
radiological manifestations of pulmonary cryptococcosis 
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are single or multiple noncalcified nodules, and pulmonary 
infiltrates, although consolidation, reticulonodular pattern 
and lobar opacities can also occur. Associated features 
may also include cavitation, lymphadenopathy and pleural 
effusion, frequently found in immunocompromised patients7. 
In the current case, multiple bilateral nodular changes were 
observed in thoracic CT scans as well as progressive 
multifocal consolidation. The lack of improvement despite 
antibiotic treatment and the newly diagnosed prostate 
carcinoma raised the suspicion of lung metastasis in this 
case. In cases of extensive or atypical radiological findings 
suggestive of malignancy or pneumonia, atypical causes of 
pneumonia should be investigated even in cases with high 
suspicion of malignancy. 
Guidelines recommend oral fluconazole 400 mg/day for 
6-12 months for the treatment of mild to moderate pulmonary 
cryptococcosis7. Severe pulmonary cryptococcosis should be 
treated similarly to CNS disease, including deoxycholate AmB 
1 mg/kg/day in combination with oral fluconazole 800 mg/day 
for the first 4 weeks, followed by oral fluconazole 400 mg/day 
for 6-12 months. There are no recommendations for the 
treatment of asymptomatic, single site infection (pulmonary 
cryptococcosis) as radiological recovery occurs regardless of 
antifungal therapy. In hitherto immunocompetent patients, 
there are some recommendations for prolonged intensive 
treatment based on poor outcomes and higher mortality5. 
However, in a subset of patients with favourable prognostic 
factors, a shorter but intensive treatment to 2 weeks may 
be used. Surgery is recommended only if symptoms persist 
despite antifungal therapy7.
CONCLUSION
In conclusion, this case emphasizes the high degree 
of suspicion of atypical infections, especially of fungal 
infections, in hitherto healthy patients with no apparent 
predisposing factors and should be considered in the 
differential diagnosis of patients diagnosed with solid 
tumors, especially prior to chemotherapy or radiotherapy.
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